Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
ATAntithrombotic Trialists' (ATT) Collaboration
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
3,668
total citations
- FWCI
- 146.65
- Percentile
- 100%
- References
- 32
Citations per year
Authors
1- ATAntithrombotic Trialists' (ATT) CollaborationCorresponding
Topics & keywords
Topics
Keywords
- Aspirin
- Medicine
- Stroke (engine)
- Myocardial infarction
- Internal medicine
- Relative risk
- Randomized controlled trial
- Vascular disease
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- AAstraZeneca
- BABrigham and Women's Hospital
- HUHarvard University
- FAFlorida Atlantic University
- LSLondon School of Hygiene and Tropical Medicine
- UDUniversità degli Studi di Milano
- UDUniversidad del Atlántico
- CRCancer Research UK
- BHBritish Heart Foundation
- UOUniversity of Oxford
- TCTrinity College Dublin
- IAIstituto Auxologico Italiano
- MRMedical Research Council